Home » Topics » Regulatory » Patents

Patents
RSS

JT discloses new compounds for Alzheimer's disease and other CNS disorders

Dec. 4, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

EGFR tyrosine kinase inhibitors from Ciba-Geigy for hyperproliferative conditions

Dec. 4, 1996

PDE IV inhibitors/cytokine inhibitors disclosed by Janssen

Dec. 4, 1996

New 5-HT1D antagonists from SmithKline Beecham

Dec. 4, 1996

McNeil describes new antipsychotic compounds

Dec. 4, 1996

New azole antifungal agents described by Zambon

Dec. 4, 1996

Bronchoselective beta-adrenergic agonists reported by Almirall

Dec. 4, 1996

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...